Financhill
Sell
42

ANIP Quote, Financials, Valuation and Earnings

Last price:
$64.37
Seasonality move :
12.72%
Day range:
$63.25 - $65.04
52-week range:
$52.50 - $70.81
Dividend yield:
0%
P/E ratio:
55.43x
P/S ratio:
2.05x
P/B ratio:
3.50x
Volume:
453.7K
Avg. volume:
302.8K
1-year change:
-4.42%
Market cap:
$1.4B
Revenue:
$614.4M
EPS (TTM):
-$1.14

Earnings Data

Next earnings date for ANIP
May 09
2025
Most recent earnings per share
-$0.55
Missed by $1.99
(Feb 28/2025)
Consensus Estimate
$1.44
(Feb 28/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ANIP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 $179.8M -- -- $1.35 --
02/28/2025 Q4 $175.4M $190.6M -$0.55 $1.44 -$1.99
11/08/2024 Q3 $144.4M $148.3M -$1.27 $1.09 -$2.36
08/06/2024 Q2 $129.1M $138M -$0.14 $0.95 -$1.09
05/10/2024 Q1 $126M $137.4M $0.82 $1.00 -$0.18
02/29/2024 Q4 $124.9M $131.7M $0.02 $0.86 -$0.84
11/08/2023 Q3 -- -- $0.45 $0.84 -$0.39
08/09/2023 Q2 -- -- $0.29 $0.67 -$0.38
05/08/2023 Q1 -- -- $0.06 $0.35 -$0.29
03/09/2023 Q4 -- -- -$0.28 $0.67 -$0.95
11/09/2022 Q3 -- -- -$0.55 $0.55 -$1.10
08/08/2022 Q2 -- -- -$0.94 $0.22 -$1.16
05/10/2022 Q1 -- -- -$1.27 $0.09 -$1.36
03/15/2022 Q4 -- -- -$1.72 $0.74 -$2.46
11/01/2021 Q3 -- -- -$0.37 $0.70 -$1.07
08/06/2021 Q2 -- -- -$1.17 $0.61 -$1.78
05/07/2021 Q1 -- -- $0.01 $0.71 -$0.70
03/09/2021 Q4 -- -- -$0.30 $0.94 -$1.24
11/05/2020 Q3 -- -- $0.04 $0.88 -$0.84
08/06/2020 Q2 -- -- -$1.03 $0.75 -$1.78
05/07/2020 Q1 -- -- -$0.59 $0.89 -$1.48
02/27/2020 Q4 -- -- -$0.41 $1.18 -$1.59
11/06/2019 Q3 -- -- $0.32 $1.43 -$1.11
08/07/2019 Q2 -- -- -- $1.29 --
05/09/2019 Q1 -- -- -- $1.05 --
02/27/2019 Q4 -- -- -- $1.24 --
11/06/2018 Q3 -- -- -- $1.17 --
08/07/2018 Q2 -- -- -- -- --
05/08/2018 Q1 -- -- -- -- --
02/27/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- -- -- --
08/03/2017 Q2 -- -- -- -- --
05/04/2017 Q1 -- -- -- -- --
03/02/2017 Q4 -- -- -- -- --
11/03/2016 Q3 -- -- -- -- --
08/04/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
02/23/2016 Q4 -- -- -- -- --
11/03/2015 Q3 -- -- -- -- --
08/04/2015 Q2 -- -- -- -- --
05/05/2015 Q1 -- -- -- -- --

ANI Pharmaceuticals Earnings Questions

  • How Much did ANI Pharmaceuticals Generate in Revenue Last Quarter?

    ANI Pharmaceuticals reported $190.6M worth of top line sales in its most recent quarter.

  • Did ANI Pharmaceuticals Beat Earnings Last Quarter?

    ANI Pharmaceuticals announced earnings per share of -$0.55 which represents a miss of analyst forecast a $1.44 per share.

  • Is ANI Pharmaceuticals Profitable?

    ANI Pharmaceuticals reported $110.3M that represents $5.67 per share over the last quarter.

  • What is the Analyst Consensus for ANI Pharmaceuticals EPS Next Year?

    ANI Pharmaceuticals's earnings are forecast to grow from -$1.04 per share to $5.01 per share next year representing an increase of 489.02%.

  • When is ANI Pharmaceuticals's Earnings Date?

    ANI Pharmaceuticals's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
69
SIG alert for Mar 20

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
36
HQY alert for Mar 20

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock